National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

被引:8
|
作者
Gori, Niccolo [1 ,2 ]
Chiricozzi, Andrea [1 ,2 ]
Marsili, Franco [3 ]
Ferrucci, Silvia Mariel [4 ]
Amerio, Paolo [5 ]
Battarra, Vincenzo [6 ]
Campitiello, Salvatore [7 ]
Castelli, Antonio [8 ]
Congedo, Maurizio [9 ]
Corazza, Monica [10 ]
Cristaudo, Antonio [11 ]
Fabbrocini, Gabriella [12 ]
Girolomoni, Giampiero [13 ]
Malara, Giovanna [14 ]
Micali, Giuseppe [15 ]
Palazzo, Giovanni [16 ]
Parodi, Aurora [17 ]
Patrizi, Annalisa [18 ]
Pellacani, Giovanni [19 ]
Pigatto, Paolo [20 ]
Provenzano, Eugenio [21 ]
Quaglino, Pietro [22 ]
Romanelli, Marco [23 ]
Rossi, Mariateresa [24 ]
Savoia, Paola [25 ]
Peris, Ketty [1 ,2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci Med Chirurg, UOC Dermatol, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Med Chirurg Traslaz, Dermatol, I-00168 Rome, Italy
[3] Versilia Hosp, Dermatol Unit, ASL 12, I-55049 Lido Di Camaiore, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, I-20122 Milan, Italy
[5] Univ G dAnnunzio, Dept Med & Aging Sci, Dermatol Clin, I-66100 Chieti, Italy
[6] AORN St Anna & San Sebastiano, Unit Dermatol, I-81100 Caserta, Italy
[7] ASL Salerno, Osped Tortora Pagani, UOC Dermatol, I-84016 Salerno, Italy
[8] San Donato Hosp, Dermatol Unit, ASL 8, I-52100 Arezzo, Italy
[9] Vito Fazzi Hosp, Sect Dermatol, Piazza Filippo Muratore, I-73100 Lecce, Italy
[10] Univ Ferrara, Dept Med Sci, Sect Dermatol & Infect Dis, I-44121 Ferrara, Italy
[11] Ist Dermatol San Gallicano IRCSS, IFO, I-00100 Rome, Italy
[12] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
[13] Univ Verona, Dept Med, Sect Dermatol & Venereol, I-37129 Verona, Italy
[14] Grande Osped Metropolitano Bianchi Melacrino Mor, Struttura Complessa Dermatol, I-89129 Reggio Di Calabria, Italy
[15] Univ Catania, Dermatol Clin, I-95123 Catania, Italy
[16] Osped Distrettuale Tinchi, Ambulatorio Dermatol, I-75015 Pisticci, Italy
[17] Univ Genoa, Osped, Policlin San Martino IRCCS, DiSSal Sect Dermatol, I-16132 Genoa, Italy
[18] Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, I-40138 Bologna, Italy
[19] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Dermatol Clin, I-00161 Rome, Italy
[20] IRCCS Osped Ortped Galeazzi, Dept Med Surg & Odntiatr Sci, I-20161 Milan, Italy
[21] Mariano Santo Hosp, Unit Dermatol, I-87100 Cosenza, Italy
[22] Univ Turin, Dept Med Sci, Dermatol Clin, I-10121 Turin, Italy
[23] Univ Pisa, Dermatol Dept, Via Roma 67, I-56126 Pisa, Italy
[24] Univ Brescia, Dept Dermatol, I-25121 Brescia, Italy
[25] Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy
关键词
atopic dermatitis; information campaign; early diagnosis; MANAGEMENT; DUPILUMAB; MODERATE; DERMATOLOGY; GUIDELINES; DIAGNOSIS; CONSENSUS; CRITERIA; CHILDREN; ECZEMA;
D O I
10.3390/jcm11175204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
    Fuxench, Zelma C. Chiesa
    Block, Julie K.
    Boguniewicz, Mark
    Boyle, John
    Fonacier, Luz
    Gelfand, Joel M.
    Grayson, Mitchell H.
    Margolis, David J.
    Mitchell, Lynda
    Silverberg, Jonathan, I
    Schwartz, Lawrence
    Simpson, Eric L.
    Ong, Peck Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (03) : 583 - 590
  • [22] Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality-of-life measure for adult atopic dermatitis
    Wang, A. R.
    Dunlap, R. R.
    Darwish, M. A.
    Simpson, E. L.
    Hanifin, J. M.
    Qureshi, A. A.
    Du, L.
    Drucker, A. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1211 - 1212
  • [23] ANALYSIS OF THE INDIVIDUAL ECONOMIC BURDEN (BORNE-COST BY THE PATIENTS) IN ADULT PATIENTS WITH ATOPIC DERMATITIS
    Ezzedine, K.
    Reguiai, Z.
    Seneschal, J.
    Merhand, S.
    Heas, S.
    Misery, L.
    Taieb, C.
    VALUE IN HEALTH, 2017, 20 (09) : A810 - A810
  • [24] Initial validation of the Burden of Disease in Atopic Eczema (BODE) instrument, a quality of life measure for adult atopic dermatitis
    Wang, A.
    Dunlap, R.
    Darwish, M.
    Simpson, E.
    Hanifin, J.
    Qureshi, A.
    Drucker, A.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 43 - 43
  • [25] Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment
    Ariens, Lieneke F. M.
    van Nimwegen, Kirsten J. M.
    Shams, Madan
    de Bruin, Digna T.
    van der Schaft, Jorien
    van Os-Medendorp, Harmieke
    De Bruin Weller, Marjolein
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (09) : 762 - 768
  • [26] Patients with adult- and late childhood-onset atopic dermatitis report a higher burden of disease severity than patients with early childhood-onset atopic dermatitis.
    Ong, Peck Y.
    Fuxench, Zelma Chiesa
    Fonacier, Luz S.
    Schwartz, Lawrence B.
    Grayson, Mitchell H.
    Block, Julie
    Mitchell, Lynda
    Gelfand, Joel M.
    Silverberg, Jonathan I.
    Margolis, David J.
    Boguniewicz, Mark
    Simpson, Eric L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB130 - AB130
  • [27] Research Gaps in Quality of Life and Economic Burden of Atopic Dermatitis The National Eczema Association Burden of Disease Audit
    Drucker, Aaron M.
    Wang, Annie R.
    Qureshi, AbrarA.
    JAMA DERMATOLOGY, 2016, 152 (08) : 873 - 874
  • [28] The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017
    Urban, Katelyn
    Chu, Sherman
    Giesey, Rachel L.
    Mehrmal, Sino
    Uppal, Prabhdeep
    Nedley, Natalie
    Delost, Gregory R.
    JAAD INTERNATIONAL, 2021, 2 : 12 - 18
  • [29] SEBACEOUS GLANDS IN UNINVOLVED SKIN OF PATIENTS SUFFERING FROM ATOPIC-DERMATITIS
    WIRTH, H
    GLOOR, M
    STOIKA, D
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1981, 270 (02) : 167 - 169
  • [30] Problem of "corticosteroid phobia" among the patients suffering from atopic dermatitis - review
    Jaworek, Andrzej
    Jaworek, Magdalena
    Szafraniec, Krystyna
    Zalewski, Adam
    Kurzawa, Ryszard
    Wojas-Pelc, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (03): : 143 - 149